| 
      
      | CCT 2004October 21(thu.)-23(sat.), 2004
 Kobe International Exhibition Hall
 Portopia Hotel
 
CCT 2005October 22(thu.)-24(sat.), 2005
 |   
          |  |  |   
          | Percutaneous coronary intervention now 
            occupies a major role in the treatment of ischemic heart disease. 
            Restenosis remains Intervention’s Achilles heel, but new approaches 
            to stenting technique combined with the efficacy of radiation therapy 
            for in-stent restenosis and the anti-restenotic properties of drug-eluting 
            stents have enhanced the long-term effectiveness and reliability of 
            interventional therapies across-the-board. 
 Advances in i
  nterventional 
            devices have been startling, and these advances point the way towards 
            two future paths for the clinical application of the newly available 
            technologies. One is to use these devices for established best-practice 
            intervention to intervene in the lesion ever more speedily and ever 
            less invasively, with the increasing use of the radial approach for 
            excellent stenting results being the obvious example. The other is 
            to exploit these new devices to intervene in lesions that until now 
            have been untreatable, all the time trying to guarantee higher and 
            higher procedural success and safety rates, namely in intervention 
            for chronic total occlusions and left main trunk disease. While decisions 
            on how best to reflect technological advance in individual cases are 
            the responsibility of the operator, this responsibility comes with 
            the obligation for every operator to be armed with the widest possible 
            array of treatment options and to bring the full range of a wealth 
            of experience and expertise to bear on everyday practice. The non-invasive 
            nature of coronary intervention gives it an enduring appeal over bypass 
            surgery, which is not to denigrate bypass surgery, which has itself 
            seen impressive advances, such as in the use of arterial grafts but 
            the future will surely see these two strategies attaining ever higher 
            levels of sophistication and advancing in tandem to provide ever better 
            treatment for ischemic heart disease. 
 The CCT2003 will offer a significant forum for fully exploring the 
            exciting realities of state-of-the-art coronary intervention, peripheral 
            intervention and coronary bypass surgery and their application in 
            “Real World” procedures. We look forward to seeing you there.
 |  
 
 |